Samyang Holdings Appoints Lee Young-jun, Head of Biopharm Group, as CEO... Dual CEO System Maintained

[Asia Economy Reporter Song Seung-yoon] Samyang Holdings announced on the 30th that it held its regular shareholders' meeting and board of directors meeting at the Samyang Group headquarters in Jongno-gu, Seoul, and newly appointed Lee Young-jun, head of the Biopharm Group, as CEO.

Accordingly, Samyang Holdings will operate under a dual CEO system with Eom Tae-woong and Lee Young-jun. At the shareholders' meeting held that day, five agenda items were presented, including approval of the financial statements, partial amendment of the articles of incorporation, appointment of directors, appointment of audit committee members, and approval of the director remuneration limit, all of which were approved as originally proposed.

This content was produced with the assistance of AI translation services.